Many investors take on an operating thesis that, by law, the obligations of investment companies are not the obligations of the investor. They apply this whether their fund has invested in the securities of a limited partnership, a limited liability company or a corporation.

In the first of two episodes, McGuireWoods partner Mark Freedlander joins

McGuireWoods has long been an avid supporter of the advancement of professional women. As part of our initiative seeking to expand the leadership of women in private equity, we are continuing our series of profiling women leaders in private equity. We are hopeful that this series will serve to inspire other women to pursue their

Viewside Capital Partners and Morningside Group have co-led a $15 million series A funding round in Resilience Lab, according to a news release.

Resilience Lab, based in New York, is a mental health technology company. Founded in 2019, the company’s platform is designed to help clients connect to therapists and participate in in-person,

On Oct. 28, the U.S. Court of Appeals for the Fourth Circuit vacated and remanded for reconsideration a district court order certifying a class of mortgage borrowers. The decision, which relies on the U.S. Supreme Court’s decision in TransUnion LLC v. Ramirez, provides further ammunition for the argument that all putative class members must

Accelmed Partners has announced it has invested $35 million in SKNV.

SKNV, based in Pompano Beach, Fla., develops medications and skincare solutions for dermatology practices. Founded in 2016 and formerly Sincerus Pharmaceuticals and Prescriber’s Choice, SKNV states it produces medicines for the 12 most common dermatological diagnoses.

Accelmed, based in Aventura, Fla., is a

The Vistria Group and GHO Capital Partners will acquire a controlling interest in Alcami Corp. from Madison Dearborn Partners (MDP) and Ampersand Capital Partners, according to a news release.

Alcami, based in Wilmington, N.C., is a contract development, testing and manufacturing organization for pharma and biotech companies. Founded in 1979, the company provides

GTCR has announced it has acquired Biocoat Holdings.

Biocoat, based in Horsham, Pa., is a provider of medical coatings products and services for medical devices in the interventional sector. Founded in 1991, the company specializes in biocompatible hydrophilic coatings.

GTCR, based in Chicago, pursues a wide range of investments in several industries, including healthcare.